Champions Oncology (CSBR) Net Cash Flow Growth (1y) (2011 - 2026)
Champions Oncology (CSBR) Net Cash Flow Growth (1y) (2011 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
NCF Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
198.34% |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
467.41% |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
-14,223.53% |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
453.08% |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
- |
| 10 |
Champions Oncology |
78.46 Mn |
71.46 Mn |
13.89 Mn |
-410.04% |
| Date | Value |
|---|
| Jan 31, 2026 |
-410.04% |
| Oct 31, 2025 |
-1,210.87% |
| Jul 31, 2025 |
97.08% |
| Apr 30, 2025 |
455.84% |
| Jan 31, 2025 |
142.87% |
| Oct 31, 2024 |
-121.43% |
| Jul 31, 2024 |
105.22% |
| Apr 30, 2024 |
-21.15% |
| Jan 31, 2024 |
-227.59% |
| Oct 31, 2023 |
-76.73% |
| Jul 31, 2023 |
-453.11% |
| Apr 30, 2023 |
-599.02% |
| Jan 31, 2023 |
-79.11% |
| Oct 31, 2022 |
253.51% |
| Jul 31, 2022 |
-37.74% |
| Apr 30, 2022 |
111.16% |
| Jan 31, 2022 |
448.75% |
| Oct 31, 2021 |
-51.37% |
| Jul 31, 2021 |
50.75% |
| Apr 30, 2021 |
-154.19% |
